Kane Biotech signs Canadian distribution agreement with Ontario Medical Supply
AI Summary- Kane Biotech signed a non-exclusive Canadian distribution agreement with Ontario Medical Supply.
- OMS will sell two revyve wound products cleared by the U.S. FDA and approved by Health Canada.
- Ontario Health atHome served more than 680,000 patients and recorded 11.1 million nursing visits in 2024–25.